Evidence map›Paper›PMID 41550514›Full record

ArticleReproductive medicine and biology

Both Oocyte Hyperresponse and Oocyte Vitrification Are Safe Procedures Regarding Embryo Euploidy: A Real-World Study Involving Almost 200 000 Oocytes.

Roberto Matorras, Silvia Pérez-Fernández, Borja Santos-Zorrozua, Aila Coello, Silvia Sierra, Marcos Ferrando, Zaloa Larreategui, Iker Malaina, Carmen Rubio, Ana Cobo and 1 more

Abstract read
In one paragraph

Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Roberto MatorrasInstituto Valenciano de Infertilidad (IVI), IVIRMA, IVI Bilbao Bilbao Spain.
Silvia Pérez-FernándezBiobizkaia Health Research Institute Baracaldo Spain.
Borja Santos-ZorrozuaBiobizkaia Health Research Institute Baracaldo Spain.
Aila CoelloInstituto Valenciano de Infertilidad (IVI), IVIRMA, IVI Valencia Valencia Spain.
Silvia SierraHuman Reproduction Unit Cruces University Hospital Baracaldo Spain.
Marcos FerrandoInstituto Valenciano de Infertilidad (IVI), IVIRMA, IVI Bilbao Bilbao Spain.ORCID https://orcid.org/0000-0003-4966-9760
Zaloa LarreateguiInstituto Valenciano de Infertilidad (IVI), IVIRMA, IVI Bilbao Bilbao Spain.
Iker MalainaDepartment of Mathematics, Faculty of Science and Technology University of the Basque Country Vizcaya Spain.
Carmen RubioR&D Department, Igenomix (Vitrolife Group) Valencia Spain.
Ana CoboInstituto Valenciano de Infertilidad (IVI), IVIRMA, IVI Valencia Valencia Spain.
Maitane GantxegiBiobizkaia Health Research Institute Baracaldo Spain.ORCID https://orcid.org/0009-0008-1813-5823

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To ascertain whether ovarian hyperresponse and oocyte vitrification (OV) are associated with an increase in embryo aneuploidy. Methods: Retrospective study involving 197 629 retrieved oocytes. We studied the euploidy rate (ER), the ER according to the number of retrieved oocytes (ERaRO) and according to the number of metaphase II oocytes (MIIO) (ERaMII), and the quotient "MIIO/retrieved oocytes" or mature oocyte rate (MOR). Results: The maximal ERaRO corresponded when only one oocyte was recovered (27% ± 44%), and was somewhat lower when two oocytes were retrieved (14% ± 31%). From the 3rd oocyte until the 36th oocyte, the ERaRO remained constant at around 10%. Regarding MIIO, a similar pattern was observed. For a given number of oocytes, usually the ER was higher if MOR was 100%. Moreover, even when considering only cases with a 100% MOR, the ER was significantly higher in cases where there were 1-2 MIIO. Concerning OV, the regression analysis after adjustment showed that vitrified oocytes had a similar rate of aneuploidy to fresh oocytes. Conclusions: Both ovarian hyperresponse and OV are safe procedures concerning embryo euploidy. The better ER obtained, especially in cases with 1-2 oocytes, opens a new line of research concerning the superior oocyte quality from the point of view of the euploidy of cycles with 1-2 oocytes.

Indexed as

aneuploidyeuploidy ratemetaphase II oocytesoocyte vitrificationovarian hyperresponse

Identifiers

PMID41550514
PMCPMC12810404

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.